Skip to main content

Homocysteine & MTHFR

Cardiovascular disease (CVD) remains a leading cause of morbidity and mortality worldwide, prompting researchers to explore various risk factors that contribute to its development. Among these factors, homocysteine, an amino acid produced during the metabolism of methionine, has gained attention for its potential association with cardiovascular diseases.

What is Homocysteine?

Homocysteine is a naturally occurring amino acid in the body that is produced during the breakdown of methionine, an essential amino acid obtained from dietary proteins. Normally, homocysteine is converted into cysteine or re-methylated to methionine, both of which are essential for various physiological processes. The balance between homocysteine production and its conversion is crucial for maintaining cardiovascular health.

The Homocysteine-CVD Link: A Scientific Perspective

Numerous studies have explored the relationship between elevated homocysteine levels and cardiovascular diseases. Elevated homocysteine has been associated with a higher risk of atherosclerosis, coronary artery disease, stroke, and venous thromboembolism. The underlying mechanisms through which homocysteine contributes to cardiovascular pathology are complex and multifaceted.

One prominent hypothesis suggests that elevated homocysteine levels may lead to endothelial dysfunction, a condition where the cells lining the blood vessels lose their normal function. Endothelial dysfunction is a key factor in the development of atherosclerosis, a condition characterized by the buildup of fatty deposits on arterial walls. Additionally, homocysteine has been implicated in promoting oxidative stress and inflammation, both of which play pivotal roles in the progression of cardiovascular diseases.

Risk Factors and Causes of Elevated Homocysteine

Several factors can contribute to elevated homocysteine levels. Genetic factors, certain medical conditions (such as kidney disease), and specific medications can influence homocysteine metabolism. However, the most significant modifiable factors are related to lifestyle and diet. Inadequate intake of B vitamins, particularly B6, B12, and folate, can impair the normal metabolism of homocysteine, leading to its accumulation.

Prevention and Intervention Strategies

Given the potential link between homocysteine and cardiovascular disease, there has been interest in exploring interventions to lower homocysteine levels. Adequate intake of B vitamins, either through dietary sources or supplements, has been shown to effectively lower homocysteine levels. However, the evidence regarding the impact of homocysteine-lowering interventions on cardiovascular outcomes remains mixed.

It’s essential to note that while homocysteine is a potential risk factor for cardiovascular disease, it is just one piece of the complex puzzle. Cardiovascular health is influenced by a combination of genetic, environmental, and lifestyle factors. As such, managing overall cardiovascular risk requires a holistic approach that addresses multiple risk factors, including blood pressure, cholesterol levels, and lifestyle choices.

MTHFR and Homocysteine

A large percent of the population carries a polymorphism in an enzyme called 5,10 methyltetrahydrofolate reductase or MTHFR. This polymorphism results in a decline in a number of events that require sufficient folic acid. The effect of this enzyme defect results in a decline of the MTHFR enzyme by approximately 60 percent, leaving the folic acid cycle very sluggish.

Folic acid comes in two common forms outside the body known as folate and folic acid. Folic acid status in the US has improved since 1998 when it was added to fortified foods, yet studies show that many people are still deficient in folic acid. Folic acid is essential for the synthesis of purines (the building blocks of DNA), the synthesis of methionine (important in methylation and over 100 reactions requiring SAMe), production of many neurotransmitters, and the metabolism of homocysteine. Folic acid is absorbed by the gut and is converted to tetrahydrofolate which is converted to methylene tetrahydrofolate and then to methyltetrahydrofolate by the enzyme MTHFR. If the MTHFR polymorphism is present then the pathways reducing homocysteine, producing methionine, glutathione, phospholipids, and neurotransmitters is reduced by up to 60 percent.

Folic acid deficiency is associated with a significant increased risk of cardiovascular disease. Historically homocysteine levels have been measured as the sole risk factor for a lack of folic acid metabolism. Recent research indicates the presence of MTHFR defect, regardless of Homocysteine levels, is a stronger indicator of risk. In other words, it doesn’t matter whether homocysteine is elevated or not. If homocysteine is elevated and MTHFR is present, these are the most at risk patients.

The good news about the folate pathway, it is maintained simply by high doses of folic acid, which will drive the pathway, just like water spilling over a dam, or by taking the form of folic acid that bypasses the need for MTHFR, called 5 Methyltetrahydrofolate (5-MTHF). We recommend a little of both. Other cofactors that also help drive the folate cycle are essential and include vitamins B2 (riboflavin), B6 (pyridoxine), and B12 (cobalamin). Those with the MTHFR are recommended to take a specifically formulated blend of folic acid and co-factors required to maximize folic acid pathways.

For so many patients who have lived years or decades without knowing they had a MTHFR defect, it is imperative to treat it correctly now. A single blood draw is all that is required to determine the presence of MTHFR. Those who have any symptom of MTHFR polymorphism, or extended family history, should be tested and treated.

The relationship between homocysteine, MTHFR, and cardiovascular disease is a topic of ongoing research and debate within the scientific community. While elevated homocysteine levels and MTHFR polymorphisms have been associated with an increased risk of cardiovascular events, the exact mechanisms and the extent to which homocysteine or MTHFR directly contributes to CVD remain subjects of investigation. As our understanding of this relationship continues to evolve, it emphasizes the importance of a comprehensive approach to cardiovascular health that includes lifestyle modifications, regular medical check-ups, and a balanced diet to address multiple risk factors.